Ren He Xu
Geen lopende functies
Profiel
Ren He Xu was the founder of ImStem Biotechnology, Inc. which was founded in 2012, where he held the title of Director & Chief Scientific Officer.
He also worked as an Independent Director at NanHua Bio-medicine Co., Ltd.
Dr. Xu earned a doctorate degree from Bar-Ilan University in 1994 and another doctorate degree from the University of Tokyo in 1999.
He also earned a graduate degree from Central South University in 1987 and an undergraduate degree from the University of South China in 1983.
Eerdere bekende functies van Ren He Xu
| Bedrijven | Functie | Einde |
|---|---|---|
| LANDFAR BIO-MEDICINE CO., LTD | Director/Board Member | - |
ImStem Biotechnology, Inc.
 ImStem Biotechnology, Inc. Medical SpecialtiesHealth Technology ImStem Biotechnology, Inc. operates as a biotechnology company. It focuses on developing cell therapeutic products. Its cell therapeutic products are derived from human pluripotent stem cells for tissue repair, treatment of neural, heart, vascular, blood system diseases and autoimmune diseases. The company was founded by Xinghua Victor Pan, Ren-He Xu, Michael Men, and Xiaofang Wang in June 2012 and is headquartered in Farmington, CT. | Founder | - |
Opleiding van Ren He Xu
| Bar-Ilan University | Doctorate Degree |
| University of Tokyo | Doctorate Degree |
| Central South University | Graduate Degree |
| University of South China | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| LANDFAR BIO-MEDICINE CO., LTD | Retail Trade |
| Bedrijven in privébezit | 1 |
|---|---|
ImStem Biotechnology, Inc.
ImStem Biotechnology, Inc. Medical SpecialtiesHealth Technology ImStem Biotechnology, Inc. operates as a biotechnology company. It focuses on developing cell therapeutic products. Its cell therapeutic products are derived from human pluripotent stem cells for tissue repair, treatment of neural, heart, vascular, blood system diseases and autoimmune diseases. The company was founded by Xinghua Victor Pan, Ren-He Xu, Michael Men, and Xiaofang Wang in June 2012 and is headquartered in Farmington, CT. | Health Technology |
